l ] Shares Pfenex Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • April 23rd, 2015 • Pfenex Inc. • Pharmaceutical preparations • New York
Pfenex Inc., a Delaware corporation (the “Company”), and certain stockholders of the Company named in Schedule II hereto (the “Selling Stockholders”), propose to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [ l ] shares (the “Firm Shares”) of Common Stock, $0.001 par value per share (the “Common Stock”), of the Company. Of the [ l ] shares of the Firm Shares, [ l ] are being sold by the Company and [ l ] are being sold by the Selling Stockholders. The Selling Stockholders have also granted to the several Underwriters an option to purchase up to [ l ] additional shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Underwriting Agreement are herein collectively called the “Securities.”
DEVELOPMENT AND LICENSE AGREEMENT by and between PFENEX INC. and HOSPIRA BAHAMAS BIOLOGICS LTD. February 9, 2015Development and License Agreement • April 23rd, 2015 • Pfenex Inc. • Pharmaceutical preparations • New York
This DEVELOPMENT AND LICENSE AGREEMENT (this “Agreement”) is entered into as of February 9, 2015 (the “Signature Date”) by and between Pfenex Inc., a Delaware corporation (“Pfenex”), and Hospira Bahamas Biologics Ltd., a company incorporated under the laws of the Bahamas (“Hospira”).
